Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research Units
Projects
Activities
Datasets
Equipment
Prizes
Press / Media
Search by expertise, name or affiliation
In Vivo Validation of Glutamate-Aspartate Antiporter EAAT1 as a Therapeutic Target for T-Cell Acute Lymphoblastic Leukaemia
Hoogenkamp, Maarten
(Principal Investigator)
Cancer and Genomic Sciences
Overview
Project Details
Short title
In Vivo Validation of Glutamate-Aspartate Antiporter EAAT1 as a Therapeutic Target for T-Cell Acute Lymphoblastic Leukaemia
Status
Finished
Effective start/end date
1/01/20
→
31/12/20
Funding
Cancer Research Uk
View all
View less